CST | HPV prevalence (% (n/N)) | OR (95% CI) (p-value#) | HR-HPV prevalence (% (n/N)) | OR (95% CI) (p-value#) | HIV prevalence (% (n/N)) | OR (95% CI) (p-value#) |
---|---|---|---|---|---|---|
CST-1 | 51.2 (65/127) | Ref | 36.2 (46/127) | Ref | 33.9 (43/127) | Ref |
CST-2 | 54.5 (12/22) | 1.1 (0.5–2.8) 0.821 | 54.5 (12/22) | 2.1 (0.8–5.3) 0.154 | 40.9 (9/22) | 1.4 (0.5–3.4) 0.629 |
CST-3 | 57.1 (12/21) | 1.3 (0.5–3.2) 0.645 | 42.9 (9/21) | 1.3 (0.5–3.4) 0.629 | 19.0 (4/21) | 0.5 (0.1–1.5) 0.213 |
CST-5 | 70.5 (31/44) | 2.3 (1.1–4.7) 0.034 | 61.4 (27/44) | 2.8 (1.4–5.7) 0.005 | 50.0 (22/44) | 2.0 (1.0–3.9) 0.072 |